Are you using Internet Explorer?
PIAA has found compatibility issues with Internet Explorer Version 11. This will impact Meeting Registrations, Store purchases, and other protected pages on the PIAA website.

Click here for easy-to-follow information to optimize your browser. It is a one-time fix!

Potential MPL Issues in Genetic Testing

Wednesday, February 21, 2018
2:00-3:00 p.m. ET (1 p.m. CT, Noon MT, 11 a.m. PT)

The webinar is FREE for PIAA members. Click here for on-demand access.

Sponsored by:


Genetic counseling and testing for patients at risk of hereditary cancer is an important consideration for any physician who may be involved in diagnosing these conditions. Among matters to consider for MPL are the relative accuracy of the tests, the requisite follow-up, the potential clinical decisions to be made based on the test results, and the related issues of costs and unnecessary treatment.

This webinar will provide an overview of the cancers known to be linked to genetic mutations and the current guides for screening at-risk patients. In addition, the speakers will present case studies— MPL lawsuits— and, based on what happened in these cases, make an estimate of the potential exposure that MPL carriers could be facing in insuring physicians who use these tests. The presentation will conclude with practical strategies that MPL carriers can use as they consider the possible risks entailed in genetic testing.


  P. Divya Parikh
Vice President of Research & Public Policy



Victor Cotton MD, JD, President, Law and Medicine


Holly J. Pederson MD, Director, Medical Breast Services, Cleveland Clinic; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine